Manufacturing: Page 14

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Improving Advocacy Relations

    Improving Advocacy relations By Elisabeth Pena By forming relationships with advocacy organizations, pharmaceutical companies can better serve their target patient populations, which in turn will give them allies in the court of public opinion. P harmaceutical companies are in the middle of a pub...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    Your Source for Life-Sciences Events and Conference Information Professional education is an ongoing endeavor for most executives. PharmaVOICE has partnerships with every major conference provider serving the life-sciences industry. PharmaVOICE is distributed at more than 150 industry events a ye...

    By PharmaVoice Team • Jan. 2, 2008
  • test tube gene Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Cell and gene therapies

    How the industry is overcoming hurdles in cell and gene therapy space and pushing for the next generation of treatments.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Executive Appointments and Promotions in the Healthcare Industry Featured Talent: Pharma POOL Michael D. Kishbauch, Achillion Pharmaceuticals Kee Moore, STADA Pharmaceuticals Luis Vélez, STADA Pharmaceuticals Dr. Michael Shalmi, Novo Nordisk Biotech POOL Katrine Bosley, Compound Therapeutics ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Talent Pool Executive Appointments and Promotions Pharma POOL Michael D. Kishbauch Achillion Appoints CEO Achillion Pharmaceuticals has named Michael D. Kishbauch CEO. Mr. Kishbauch replaces Marios Fotiadis, who was acting as interim CEO. Before joining Achillion, New Haven, Conn., Mr. Kishbauch ...

    By PharmaVoice Team • Jan. 2, 2008